165 related articles for article (PubMed ID: 34622843)
21. Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
Huang KH; Tai MC; Lee LC; Weng TH; Chen YH; Lin LF; Chen JT; Lu DW; Chen CL
Medicine (Baltimore); 2018 Mar; 97(9):e0047. PubMed ID: 29489658
[TBL] [Abstract][Full Text] [Related]
22. Early phase Vogt-Koyanagi-Harada Disease in Nepalese Elderly woman: A case report.
Bahadur BT; Gurung S; Singh S; Aryal M
Nepal J Ophthalmol; 2020 Jan; 12(23):146-152. PubMed ID: 32799253
[TBL] [Abstract][Full Text] [Related]
23. [Vogt-Koyanagi-Harada syndrome in children - a case report].
Bušányová B; Tomčíková D; Gerinec A
Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
[TBL] [Abstract][Full Text] [Related]
24. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
25. The spectrum of Vogt-Koyanagi-Harada disease in South India.
Murthy SI; Moreker MR; Sangwan VS; Khanna RC; Tejwani S
Int Ophthalmol; 2007; 27(2-3):131-6. PubMed ID: 17318321
[TBL] [Abstract][Full Text] [Related]
26. Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease.
Khalifa Y; Loh AR; Acharya NR
Ocul Immunol Inflamm; 2009; 17(6):431-3. PubMed ID: 20001265
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
28. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
[TBL] [Abstract][Full Text] [Related]
29. Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Caso F; Rigante D; Vitale A; Costa L; Bascherini V; Latronico E; Franceschini R; Cantarini L
Clin Rheumatol; 2015 Oct; 34(10):1817-20. PubMed ID: 25224382
[TBL] [Abstract][Full Text] [Related]
30. Clinical Presentation, Management, and Long-Term Outcome of Pars Planitis, Panuveitis, and Vogt-Koyanagi-Harada Disease in Children and Adolescents.
Reiff A
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1589-1596. PubMed ID: 31444859
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis.
Park JG; Callaway NF; Ludwig CA; Mahajan VB
Am J Ophthalmol Case Rep; 2020 Sep; 19():100859. PubMed ID: 32793845
[TBL] [Abstract][Full Text] [Related]
32. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and immunohistochemistry correlation in a case of Vogt-Koyanagi-Harada disease.
Das D; Boddepalli A; Biswas J
Indian J Ophthalmol; 2019 Jul; 67(7):1217-1219. PubMed ID: 31238472
[TBL] [Abstract][Full Text] [Related]
34. [Vogt-Koyanagi-Harada disease].
Bonnet C; Daudin JB; Monnet D; Brézin A
J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
[TBL] [Abstract][Full Text] [Related]
35. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
36. Acute retinal necrosis (ARN) following chickenpox in a patient of Vogt-Koyanagi-Harada (VKH) syndrome using immunosuppressants.
Gupta R; Tyagi M; Balakrishnan D; Rani PK
BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567136
[TBL] [Abstract][Full Text] [Related]
37. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
Han YS; Shin KS; Lee WH; Kim JY
Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
[TBL] [Abstract][Full Text] [Related]
38. Indocyanine green angiography in Vogt-Koyanagi-Harada disease: angiographic signs and utility in patient follow-up.
Herbort CP; Mantovani A; Bouchenaki N
Int Ophthalmol; 2007; 27(2-3):173-82. PubMed ID: 17457515
[TBL] [Abstract][Full Text] [Related]
39. Magnetic resonance imaging of pachymeningeal enhancement in Vogt-Koyanagi-Harada disease.
Han HJ; Kim HY; Park JH; Lee EJ; Kim DG; Shin DI
Neurol Sci; 2010 Dec; 31(6):785-8. PubMed ID: 20198496
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
